Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update

키워드

참고문헌 (35)

1. Kuter DJ, "Bone marrow fibrosis : pathophysiology and clinical significance of increased bone marrow stromal fibres", Br J Haematol, 139, pp.351~362 (2007)
2. Gömöri G, "Silver impregnation of reticulum in paraffin sections", Am J Pathol, 13, pp.993~1002 (1937)
3. Kvasnicka HM, "Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph1+ chronic myelogenous leukemia : a multicenter trial", J Clin Oncol, 19, pp.2994~3009 (2001)
4. Subramanian R, "Significance of bone marrow fibrosis in multiple myeloma", Pathology, 39, pp.512~515 (2007)
5. Vener C, "Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis", Blood, 111, pp.1862~1865 (2008)
6. Campbell PJ, "Reticulin accumulation in essential thrombocythemia : prognostic significance and relationship to therapy", J Clin Oncol, 27, pp.2991~2999 (2009)
7. Sultan C, "Acute myelodysplasia with myelofibrosis : a report of eight cases", Br J Haematol, 49, pp.11~16 (1981)
8. Arber DA, "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia", Blood, 127, pp.2391~2405 (2016)
9. Pagliuca A, "Myelofibrosis in primary myelodysplastic syndromes : a clinico-morphological study of 10 cases", Br J Haematol, 71, pp.499~504 (1989)
10. Della Porta MG, "Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes", J Clin Oncol, 27, pp.754~762 (2009)
11. Buesche G, "Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes", Leukemia, 22, pp.313~322 (2008)
12. Fu B, "Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems", Mod Pathol, 27, pp.681~689 (2014)
13. Lambertenghi-Deliliers G, "Myelodysplastic syndrome with increased marrow fibrosis : a distinct clinico-pathological entity", Br J Haematol, 78, pp.161~166 (1991)
14. Greenberg PL, "Revised international prognostic scoring system for myelodysplastic syndromes", Blood, 120, pp.2454~2465 (2012)
15. Vardiman JW, "The 2008 revision of the World Health Organization(WHO)classification of myeloid neoplasms and acute leukemia : rationale and important changes", Blood, 114, pp.937~951 (2009)
16. Verhoef GE, "Myelodysplastic syndromes with bone marrow fibrosis : a myelodysplastic disorder with proliferative features", Ann Hematol, 63, pp.235~241 (1991)
17. Della Porta MG, "Myelodysplastic syndromes with bone marrow fibrosis", Haematologica, 96, pp.180~183 (2011)
18. Kröger N, "Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis", Haematologica, 96, pp.291~297 (2011)
19. Tefferi A, "Pathogenesis of myelofibrosis with myeloid metaplasia", J Clin Oncol, 23, pp.8520~8530 (2005)
20. Steensma DP, "Myelodysplasia with fibrosis : a distinct entity?", Leuk Res, 25, pp.829~838 (2001)
21. Wang J, "Moderate to severe marrow fibrosis as a more advanced risk factor for MDS and MDS-AML patients with excess of blasts receiving allogeneic hematopoietic stem cell transplantation", Transplant Cell Ther, 27, pp.666~ (2021)
22. Manoharan A, "The reticulin content of bone marrow in acute leukaemia in adults", Br J Haematol, 43, pp.185~190 (1979)
23. Thiele J, "European consensus on grading bone marrow fibrosis and assessment of cellularity", Haematologica, 90, pp.1128~1132 (2005)
24. Fu B, "The clinical importance of moderate", severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes, 2013, pp.92, 1335~1343
25. Melody M, "Decoding bone marrow fibrosis in myelodysplastic syndromes", Clin Lymphoma Myeloma Leuk, 20, pp.324~328 (2020)
26. Ramos F, "Bone marrow fibrosis in myelodysplastic syndromes : a prospective evaluation including mutational analysis", Oncotarget, 7, pp.30492~30503 (2016)
27. Marisavljević D, "Myelofibrosis in primary myelodysplastic syndromes : clinical and biological significance", Med Oncol, 21, pp.325~331 (2004)
28. Ohyashiki K, "Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis", Cancer, 68, pp.178~183 (1991)
29. Allen EF, "A case of acute myelofibrosis with complex karyotypic changes : a type of myelodysplastic syndrome", Cancer Genet Cytogenet, 90, pp.24~28 (1996)
30. Reilly JT, "Proposed classification for the myelodysplasia", myelofibrosis syndromes, 1991, pp.79, 653~
31. Narayanan MN, "Hyperfibrotic myelodysplasia", Br J Haematol, 79, pp.653~655 (1991)
32. Maschek H, "Myelofibrosis in primary myelodysplastic syndromes : a retrospective study of 352 patients", Eur J Haematol, 48, pp.208~214 (1992)
33. Hussein K, "Profile of fibrosis-related gene transcripts and megakaryocytic changes in the bone marrow of myelodysplastic syndromes with fibrosis", Ann Hematol, 97, pp.2099~2106 (2018)
34. Scott BL, "Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia", Biol Blood Marrow Transplant, 13, pp.345~354 (2007)
35. Wang N, "Patients of myelodysplastic syndrome with mild", moderate myelofibrosis and a monosomal karyotype are independently associated with an adverse prognosis : long-term follow-up data, 2020, pp.12, 5881~5891

관련 논문AI추천